You have 9 free searches left this month | for more free features.

GNS561

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

Primary Liver Cancer Trial in Marseille (GNS561 oral tablets and capsules)

Not yet recruiting
  • Primary Liver Cancer
  • GNS561 oral tablets and capsules
  • Marseille, France
    Genoscience Pharma
Apr 25, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma, Intrahepatic Trial in Belgium, France, United States (GNS561)

Terminated
  • Hepatocellular Carcinoma
  • Cholangiocarcinoma, Intrahepatic
  • GNS561
  • New York, New York
  • +4 more
Apr 25, 2022

COVID-19 Trial in Marseille (GNS561)

Recruiting
  • COVID-19
  • GNS561
  • Marseille, France
    Genoscience Pharma
Jul 27, 2021

SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor

Completed
  • SARS-CoV-2 (COVID-19) Infection
  • Advanced or Metastatic Hematological or Solid Tumor
  • Autophagy inhibitor (GNS651)
  • +3 more
  • Lyon, Rhône, France
  • +11 more
Sep 29, 2022

Caregiver Distress, Physical Function, Quality of Life Trial in Houston (Baduanjin Qigong, Community-based, Baduanjin Qigong,

Active, not recruiting
  • Caregiver Distress
  • +2 more
  • Baduanjin Qigong, Community-based
  • Baduanjin Qigong, Internet-based
  • Houston, Texas
    University of Houston
Dec 9, 2021

Cardiovascular Diseases, Diabetes, Dyslipidemias Trial in Granada (exercise)

Completed
  • Cardiovascular Diseases
  • +4 more
  • exercise
  • Granada, Andalucía, Spain
    Department of Physiology, Faculty of Farmacy, University of Gran
Oct 24, 2016